-
Women's Health
5/20/2011
Evidence brings hope. You know the outcome of a clinical trial for a breast cancer drug or a new drug for osteoporosis could mean the difference between a healthy, active life and chronic illness or death.
-
Public Health And Government Services
5/20/2011
Navigating the complexities of clinical development for government and other subsidized programs requires a partner who has a combination of therapeutic expertise and experience in the public health sector.
-
Emerging Biopharma
5/20/2011
You're excited by the opportunities your new compound presents. However, as it advances through each stage of the clinical trial process, the cost and complexities continue to increase.
-
Medical Devices
5/20/2011
In a world of challenging and dynamic regulation, effective management of regulatory issues is essential to the maintenance of your business and to new product introduction.
-
Oncology
5/20/2011
With our fully-integrated, collaborative approach, commercial viability informs every stage of clinical development, improving your product’s chance of success at every phase.
-
Model Based Drug Development
5/20/2011
Turning healthy ideas into healthy humans has become a complex equation in the face of spiraling costs and rising scrutiny.
-
Endocrinology
5/20/2011
We can be your partner to mitigate the effects of longer timelines, additional costs, and higher risk in your clinical development program.
-
Biostatistics
5/18/2011
Quintiles was founded by biostatisticians. From this base, we know that smart biostatistics will help optimize study design and speed results.
-
Phase II/III
5/18/2011
You are challenged to develop drugs on time and to get it right the first time. We help deliver phase II clinical trials and phase III clinical trials quickly and accurately, with a commitment to exceed your expectations.
-
Clinic Profiles
5/18/2011
You want to provide a safe environment and a rewarding experience for healthy volunteers during clinical trials. Quintiles delivers that atmosphere, drawing on more than 25 years' experience handling Phase I clinical research and clinical trial monitoring.